FDA approves Pfizer's COVID-19 vaccine booster shot for children ages 12 and upBusiness Insider • 01/03/22
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 12 Years of Age and OlderBusiness Wire • 01/03/22
Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: ReutersBenzinga • 01/03/22
Pfizer Invites Public to View and Listen to Webcast of February 8 Conference Call with AnalystsBusiness Wire • 12/28/21
A Pfizer exec leading the world's vaccine efforts says a "high-growth mindset" drives innovation at the companyBusiness Insider • 12/28/21
3 Dividend Stocks That Soared More Than 50% in 2021 and Are Still Great BuysThe Motley Fool • 12/26/21
Pfizer's Status As The 'Pandemic Exterminator' Makes Them A Favorite For 2022Seeking Alpha • 12/24/21